LUMIGAN® 0.01% is an FDA-approved eyedrop medication prescribed to lower high eye pressure in patients with open-angle glaucoma or ocular hypertension.

The most common treatment to lower high eye pressure—an important, treatable risk factor in glaucoma patients—is with prescription eyedrops, such as LUMIGAN® 0.01% ophthalmic solution. LUMIGAN® 0.01% is for people who have a specific type of glaucoma, known as open-angle glaucoma, or for people who have ocular hypertension.

Indication

LUMIGAN® (bimatoprost ophthalmic solution) 0.01% is used for the reduction of high eye pressure, also called intraocular pressure (IOP), in people with open-angle glaucoma or ocular hypertension.

Dosage and administration

The recommended dosage is one drop in the affected eye(s) once daily in the evening. LUMIGAN® (bimatoprost ophthalmic solution) 0.01% should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the intraocular pressure lowering effect.
Reduction of the intraocular pressure starts approximately 4 hours after the first administration with maximum effect reached within approximately 8 to 12 hours.